Drug Approval

Blog Post

FDA’s Approval of Duvyzat (givinostat) Offers New Hope to People Living with Duchenne Muscular Dystrophy

By MDA Staff | March 21, 2024
A group of MDA advocates gather in front of the United States Capitol Building on Hill Day
Blog Post

Celebrating Our 2023 Advocacy Accomplishments

By Mark Fisher | December 20, 2023
Collage image with six photos of various MDA events and supported research
Blog Post

2023 in Review: A Letter from MDA President and CEO, Dr. Wood

By Donald S. Wood, Ph.D., President and CEO, Muscular Dystrophy Association | December 11, 2023
Graphic of the inside of a human cell
Featured Article

Q&A: Understanding Metabolic Myopathies

By MDA Staff | November 17, 2023
wooden blocks spell out the word content with word bubbles above that say news and stories and photos and blog
Blog Post

In Case You Missed It…

By MDA Staff | November 8, 2023
Blog Post

AGAMREE ® (Vamorolone), Now FDA-Approved, Offers Hope for Children Living with Duchenne Muscular Dystrophy

By MDA Staff | October 26, 2023
A young girl with blonde hair sitting on a doctor’s table as a doctor, a woman with brown hair, uses a reflex hammer on the girl’s knee. Both girl and doctor are smiling.
Featured Article

Advances in the Treatment of Friedreich Ataxia

By MDA Staff | August 8, 2023
DNA spiral pill on black background. Genetically modified food concept.
Blog Post

DMD Gene Therapy Approval Ignites Hope

By Larry Luxner | August 1, 2023
Blog Post

FDA Approves Sarepta’s ELEVIDYS for Treatment of DMD

By Sujatha Gurunathan | June 22, 2023
Blog Post

FDA Approves argenx’s Vyvgart Hytrulo for Treatment of gMG

By Sujatha Gurunathan | June 20, 2023